coronary atherosclerotic heart disease
Conditions
Interventions
Control group versus Experimental group A versus Experimental group B versus Experimental group C:Time intervention
Sponsors
Fifth Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
40 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. The aged should meet the diagnostic criteria of ischemic heart disease which was standarded by The International Society of Cardiology and association and the WHO Joint Professional Group for Standardization of Clinical Nomenclature; 2. Meeting the coronary heart disease diagnostic basis, such as the typical signs and symptoms of CHD, and with the help of clinical auxiliary examination result, at least one major coronary artery or its major branches with an internal diameter stenosis >=50% when coronary angiogram, to confirm the diagnosis; 3. The first time diagnosed myocardial infarction or recurrence of myocardial infarction in three months, included the PCI, CABG patients; 4. The aged people should have primary school education or above; 5. He or she should have a complete clinical data; 6. He or she should be volunteer to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Coronary heart disease with one or more other diseases, such as acute heart failure, cardiac shock, malignant ventricular arrhythmia, acute phase of cerebrovascular disease, cancer, hematological system diseases, severe liver and kidney dysfunction, psychopath and there are physical disorders unable to exercise rehabilitation; 2. Patients with unstable angina pectoris, arrhythmia and cardiac function grade IV or uncontrolled high blood pressure(resting systolic bp >160mmHg or resting diastolic bp >100mmHg); 3. Patients with cognitive impairment, dementia, difficulty in communicating understanding or understanding and unable to finish rehabilitation due to physical Disability; 4. The patient was diagnosed with cancer, infectious disease, inflammatory disease, kidney or liver failure, connective tissue diseases and had a history of deep vein thrombosis or pulmonary embolism; 5. Patients have a prescription of steroid drug or other immunosuppressants, cytotoxic drug, warfarin and use hormone replacement therapy; 6. The patient who is in a cardiac rehabilitation program or has previously participated in a rehabilitation program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure;blood glucose;blood lipid;Pittsburgh sleep quality index, PSQI;HAMILTON anxiety assessment Scale;SF-36;NYHA;six-minutes walking test;cardiopulmonary exercise testing; | — |
Countries
China
Contacts
Public ContactAnqin Dong
The Fifth Affiliated Hospital of Zhengzhou University
Outcome results
None listed